What Tepezza treats
Tepezza (teprotumumab) is a biologic medication used to treat thyroid eye disease (TED), also known as Graves’ orbitopathy. This condition is characterized by inflammation and swelling of the tissues around the eyes, leading to bulging eyes, double vision, and discomfort. Tepezza works by targeting and inhibiting the insulin-like growth factor-1 receptor (IGF-1R), which plays a role in the inflammatory process associated with TED.
Benefits of Tepezza
The treatment goals in the conditions Tepezza is approved to treat include reduced eye bulging, decreased double vision, and overall improvement in symptoms of thyroid eye disease. Whether an individual patient reaches them varies, and is assessed by the prescribing clinician. The treatment can lead to a noticeable reduction in inflammation and a better quality of life for those affected by TED. The intravenous infusion schedule supports management of the disease with regular monitoring of patient response.
Possible Side Effects of Tepezza
Some patients experience side effects, including infusion-related reactions such as fever, chills, and nausea. Other potential side effects include muscle pain, headache, and fatigue. Serious side effects can include an increased risk of high blood sugar and other metabolic issues. It is important to monitor for any adverse effects and report them to your healthcare provider.
How infusion works at Prime
Tepezza is administered at our infusion centers across New York and Atlanta. Our dedicated care team coordinates every step of your treatment with your prescribing physician.
Getting started
Patients: if you have a referral for Tepezza, send us an inquiry using the form below and our care team will take it from there. Physicians: referring a patient to Prime Infusions is simple — just complete and fax or email the referral form above.
Ready to start?
For a medical emergency, call 911.
Our Infusion Centers
FAQ
Frequently asked questions
How Does Tepezza Work?
Tepezza works by binding to and inhibiting the IGF-1R, a protein involved in the inflammatory response and tissue remodeling in thyroid eye disease. By blocking this receptor, Tepezza helps to reduce the inflammation and swelling of the tissues around the eyes, leading to improved symptoms and a reduction in eye bulging and double vision. Tepezza is administered through intravenous infusion, typically given every three weeks for a total of eight doses.
Who is Tepezza For?
Tepezza is suitable for adults with moderate to severe thyroid eye disease who have not responded adequately to other treatments. It is specifically indicated for individuals with active TED who require additional therapy to manage inflammation and improve their eye symptoms. Tepezza is recommended for patients who experience significant discomfort and visual impairment due to TED.